Worth reading
26Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
20000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
10th Series of Share Acquisition Rights through Third-Party Allotment (with Exercise Price Adjustment Clause)
発行・処分する株式数
Shares delivered during the month under review: 20,000 shares (20,000 new shares and 0 treasury shares transferred)
発行済株式総数
Exercise ratio for the month under review: 0.68%. Exercise ratio subject to exercise restrictions: 0.17%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise price during the month under review: ¥118–¥151. Details and floor of the adjustment clause: Not disclosed
Number of Stock Acquisition Rights
Total number issued: 29,400 (the 200 exercised during the month under review represented 0.68% of the total issued). Number remaining unexercised as of the end of the month preceding the month under review: 1,658; as of month-end: 1,458
Procedures under the Corporate Code of Conduct
Describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters
Most recent equity financing
4 September 2025: Issuance of the 10th Stock Acquisition Rights through a third-party allotment (issue proceeds and funds raised: Not disclosed)
| Item | Details |
|---|---|
| Type of issuance or disposal | 10th Series of Share Acquisition Rights through Third-Party Allotment (with Exercise Price Adjustment Clause) |
| Number of shares to be issued or disposed of | Shares delivered during the month under review: 20,000 shares (20,000 new shares and 0 treasury shares transferred) |
| Dilution Rate | Exercise ratio for the month under review: 0.68%. Exercise ratio subject to exercise restrictions: 0.17% |
| Total number of issued shares | 14,516,700 shares (as of the end of the month preceding the month under review) → Not disclosed |
| Exercise price | Exercise price during the month under review: ¥118–¥151. Details and floor of the adjustment clause: Not disclosed |
| Number of Stock Acquisition Rights | Total number issued: 29,400 (the 200 exercised during the month under review represented 0.68% of the total issued). Number remaining unexercised as of the end of the month preceding the month under review: 1,658; as of month-end: 1,458 |
| Procedures under the Corporate Code of Conduct | Describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters |
| Most recent equity financing | 4 September 2025: Issuance of the 10th Stock Acquisition Rights through a third-party allotment (issue proceeds and funds raised: Not disclosed) |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status in March 2026 of the 10th Stock Acquisition Rights issued on 4 September 2025.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.